Influx Healthtech Limited, based in Mumbai, is a healthcare-focused CDMO established in 2020. The company offers contract manufacturing services across a wide range of products including dietary supplements, cosmetics, herbal products, veterinary feed, homecare items, APIs, and finished dosage forms like tablets, capsules, and injectables. It operates three certified manufacturing facilities in Thane, Maharashtra, spanning over 36,000 sq. ft. Combined GMP, HACCP, ISO 22000, and Halal certifications.
Price Band₹91 - ₹96 |
Dates18 Jun - 20 Jun |
GMP₹21 (21.88%) |
Subscriptions201.44 times |
Issue Size₹58.57 Crs |
18 Jun 25
20 Jun 25
23 Jun 25
24 Jun 25
24 Jun 25
25 Jun 25
Price Band₹91 - ₹96 |
Listing AtNSE SME |
IPO Issue Type100% Book Built Offer |
Fresh Issue₹48.00 Cr (0.50 Cr Shares) |
Offer For Sale₹10.56 Cr (0.11 Cr Shares) |
Total Issue₹58.57 Cr (0.61 Cr Shares) |
Face Value₹10 per equity share |
| Investor Category | Lot | Shares | Amount | |
|---|---|---|---|---|
| Individual Investor |
Minimum
1
1,200
1,15,200
Maximum
1
1,200
1,15,200
|
|||
| NII |
Minimum
2
2,400
2,30,400
|
|||
Updated as on 20-Jun-2025 19:00:19 hrs
| Investor Category | Subscription (times) | Shares Offered | Shared Bid |
|---|---|---|---|
| QIB | 137.87 | 11,59,200 | 15,98,18,400 |
| NII | 481.47 | 8,70,000 | 41,88,78,000 |
| Individual Investor | 117.70 | 20,29,200 | 23,88,42,000 |
| Total | 201.44 | 40,58,400 | 81,75,38,400 |
The estimated Grey Market Premium of Influx Healthtech IPO is ₹21 per share (21.88%)
| Particulars | Allocation |
|---|---|
| QIB | Not more than 50% of Net Offer |
| NII | Not less than 15% of Net Offer |
| Retail | Not less than 35% of Net Offer |
| Market Maker | 3,06,000 EQ Shares |
| Particulars | Mar-25 | Mar-24 | Mar-23 |
|---|---|---|---|
| Revenue from Operations | 104.85 | 99.97 | 76.06 |
| Profit after Tax | 13.37 | 11.13 | 7.20 |
| Net Worth | 36.15 | 22.78 | 11.65 |
| Total Borrowing | 0.22 | 0.32 | 0.80 |
| Total Assets | 70.30 | 41.10 | 28.30 |
| NAV per share (in ₹) | 19.91 | 12.55 | 6.42 |
| EPS - Basic (in ₹) | 7.36 | 6.13 | 3.96 |
The financial information presented is on a consolidated basis.
| KPI | KPI |
|---|---|
| EBITDA | 19.62% |
| PAT | 12.75% |
| ROE | 36.98% |
| ROCE | 49.17% |
| Debt to Equity | 0.01 |
| PE Ratio | 13.04 |
| PB Ratio | 4.82 |
| Mkt Cap (in Crs.) | 222.24 |
| Particulars | Influx Healthtech | Sudarshan Pharma Industries | Quest Laboratories |
|---|---|---|---|
| Revenue from Ops (in Crs.) | 104.85 | 502.51 | 103.91 |
| PAT (In Crs.) | 13.37 | 15.88 | 13.57 |
| EPS - Basic | 7.36 | 0.66 | 8.28 |
| NAV per share | 19.91 | 5.30 | 49.92 |
| RONW | 36.98% | 12.45% | 16.58% |
| EBITDA | 19.62% | 7.66% | 15.38% |
| PAT Margin | 12.75% | 3.16% | 13.05% |
| Price to earning (PE) | 13.04 | 48.28 | 10.38 |
| Particulars | Influx Healthtech |
|---|---|
| Revenue from Ops (in Crs.) | 104.85 |
| PAT (In Crs.) | 13.37 |
| EPS - Basic | 7.36 |
| NAV per share | 19.91 |
| RONW | 36.98% |
| EBITDA | 19.62% |
| PAT Margin | 12.75% |
| Price to earning (PE) | 13.04 |
| Sudarshan Pharma Industries | Quest Laboratories |
|---|---|
| 502.51 | 103.91 |
| 15.88 | 13.57 |
| 0.66 | 8.28 |
| 5.30 | 49.92 |
| 12.45% | 16.58% |
| 7.66% | 15.38% |
| 3.16% | 13.05% |
| 48.28 | 10.38 |
| Name | Shareholding |
|---|---|
| Munir Abdul Ganee Chandniwala | 95.00% |
| Shirin Munir Ahmed Chandniwala | 4.85% |
| Total | 99.85% |
| Name | Designation |
|---|---|
| Mr. Munir Abdul Ganee Chandniwala | Chairman & MD |
| Mr. Ashish Ghanshyam Shah | CFO |
Name: Influx Healthtech Limited
Address: 109, Ghanshyam Enclave Premises Co-op Soc Plot No. 856, Laljipada, Kandivali West, Mumbai - 400067 Maharashtra, India
Number: +91 7045997809
Email: cs@influxhealthtech.com
Website: www.influxhealthtech.com
Frequently Asked questions?
Find answers to common questions that come in your mind related to IPO.
Influx Healthtech IPO is a SME IPO having an issue size of Rs. ₹58.57 Crs. Influx Healthtech IPO is priced at ₹91 - ₹96 per share. The issue opens on 18 Jun 25 and closes on 20 Jun 25.
Influx Healthtech IPO opens on 18 Jun 25 and closes on 20 Jun 25.
The estimated Grey Market Premium of Influx Healthtech IPO is ₹21 per share (21.88%).
The minimum lot size of Influx Healthtech IPO is 1200 shares & the minimum application amount is Rs. 115200.
The allotment date of Influx Healthtech IPO is 23 Jun 25.
The listing date of Influx Healthtech IPO is 25 Jun 25.
Influx Healthtech IPO is subscribed 201.44 times.
Influx Healthtech IPO is priced at ₹91 - ₹96 per share.
Click the allotment link on Influx Healthtech IPO page of IPO360.